PDGFRA公司
PDGFRB公司
癌症研究
癌变
胶质瘤
长非编码RNA
生物
基因敲除
蛋白激酶B
PI3K/AKT/mTOR通路
MAPK/ERK通路
信号转导
核糖核酸
癌症
基因
间质细胞
细胞生物学
遗传学
主旨
作者
Anshika Goenka,Xiao Song,Deanna Tiek,Rebeca Piatniczka Iglesia,Minghui Lu,Zeng Chen,Craig Horbinski,Wei Zhang,Bo Hu,Shi‐Yuan Cheng
出处
期刊:Neuro-oncology
[Oxford University Press]
日期:2023-03-29
卷期号:25 (9): 1592-1604
被引量:1
标识
DOI:10.1093/neuonc/noad065
摘要
Abstract Background Long noncoding RNAs (lncRNAs) regulate the etiology of complex diseases and cancers, including glioblastoma (GBM). However, lncRNA-based therapies are limited because the mechanisms of action of many lncRNAs with their binding partners are not completely understood. Methods We used transcriptomic and genomic data to analyze correlations between LINC02283 and PDGFRA (platelet-derived growth factor receptor A). The biological functions of the novel lncRNA were assessed in vivo using patient-derived glioma stem-like cells (GSCs), and orthotopic GBM xenografts. Immunoblotting, qRT-PCR, RNA pull down, crosslinked RNA immunoprecipitation, fluorescence in situ hybridization, and antisense oligo-mediated knockdown were performed to explore the regulation of LINC02283 on PDGFRA signaling. Expression of LINC02283 in clinical samples was assessed using pathologically diagnosed GBM patient samples. Results We identified a novel oncogenic lncRNA, LINC02283, that is highly expressed in the PDGFRA mutation-driven cohort of glioma patients and associated with worse prognosis. LINC02283 gene co-amplifies with the PDGFRA locus and shows high correlation with PDGFRA expression. Deprivation of LINC02283 in GSCs with PDGFRA amplification mutation, attenuated tumorigenicity and enhanced survival in orthotopic GBM xenograft models, while overexpression of LINC02283 in GSCs with wild-type PDGFRA, enhances PDGFRA signaling, and decreases survival. Further, LINC02283 interacts with PDGFRA to enhance its signaling and that of its downstream targets AKT and ERK, thus promoting oncogenesis in GBM. Conclusions Our results provide strong evidence of LINC02283 as a regulator of PDGFRA oncogenic activity and GBM malignancy and support the potential of lncRNAs as possible therapeutic targets.
科研通智能强力驱动
Strongly Powered by AbleSci AI